Dr. Solomon Jacob | Parasitology | Best Researcher Award

Federal Ministry of Health, Nigeria.

Dr. Solomon Monday Jacob (JSM) is a seasoned Medical Parasitologist and a Chief Medical Laboratory Scientist at the Federal Ministry of Health, Nigeria. He serves as the Technical Lead for the National Schistosomiasis and Soil-Transmitted Helminthiasis Control Programme, playing a pivotal role in expanding Neglected Tropical Diseases (NTDs) control in Nigeria. With vast experience in malaria, onchocerciasis, lymphatic filariasis, and NTD research, he has contributed significantly to disease prevention strategies. He has published numerous research papers and collaborates with global organizations on healthcare innovations.

Profile

Orcid

🎓 Education

Dr. Solomon Jacob holds a PhD in Medical Laboratory Science with a specialization in Medical Parasitology. His academic journey has equipped him with in-depth knowledge of infectious diseases, epidemiology, and diagnostic techniques. In addition to his doctorate, he has undergone extensive training in Neglected Tropical Diseases (NTD) control programs, focusing on strategies for disease surveillance, prevention, and treatment. His expertise in disease epidemiology has enabled him to contribute significantly to public health initiatives, research projects, and policy development aimed at reducing the burden of NTDs in Nigeria and beyond.

🏢 Professional Experience

Dr. Solomon Jacob is a dedicated Program Officer for Neglected Tropical Diseases (NTDs) at the Federal Ministry of Health, Nigeria, where he plays a crucial role in formulating and implementing national disease control strategies. As a Chief Medical Laboratory Scientist, he leads technical initiatives for the Schistosomiasis & Soil-Transmitted Helminthiasis Control Programme, focusing on innovative approaches to diagnosis, treatment, and eradication efforts.

Beyond his government role, Dr. Jacob serves as a Researcher and Consultant, contributing to significant projects on Malaria, Onchocerciasis, Lymphatic Filariasis, and other NTDs. His work involves operational research, policy advisory, and capacity building to strengthen disease surveillance and control measures. Additionally, he is an Editorial Board Member for renowned scientific journals such as PLoS NTD and Elsevier, furthering his impact in global health research.

🔬 Research Interests

Neglected Tropical Diseases (NTDs) 🦠

Schistosomiasis & Soil-Transmitted Helminthiasis 🏥

Malaria & Vector-Borne Diseases 🦟

Onchocerciasis & Lymphatic Filariasis 🏨

Public Health & Disease Control Strategies

🏆 Awards & Recognitions

Recognized for strategic contributions to NTD control in Nigeria

Lead researcher in multiple operational health projects

Editorial Appointments with PLoS NTD, Elsevier

📚 Selected Publications

Schistosomiasis and Soil Transmitted Helminthiasis Among School-Age Children: Impact of 3–5 Annual Rounds of Mass Drug Administration in Ekiti State, Southwest Nigeria
🗓 2025-03-23 | Journal article | 📖 Tropical Medicine and Infectious Disease
🔗 DOI: 10.3390/tropicalmed10040085
👥 Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Akande Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.

Impact of Preventive Chemotherapy on the Prevalence of Schistosomiasis and Soil-Transmitted Helminthiasis Among School-Age Children After 3–5 Effective Rounds of Annual Mass Drug Administration in Ekiti State, Southwest Nigeria
🗓 2025-01-27 | Preprint
🔗 DOI: 10.20944/preprints202501.1916.v1
👥 Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.

Impact of Praziquantel Mass Drug Administration after Several Rounds on Schistosomiasis Among School-Aged Children in Abuja, Nigeria
🗓 2025-01-22 | Preprint
🔗 DOI: 10.20944/preprints202501.1625.v1
👥 Contributors: Solomon Monday Jacob, Sophie Y. Akinbo, Akinola Stephen Oluwole, Temitope Agbana, Zainab Omoruyi, Michael A. Okungbowa, Diehl Jan-Carel, Fredrick O. Akinbo

Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis and Soil-Transmitted Helminths in Ekiti State, South West, Nigeria
🗓 2024-10-25 | Journal article | 📖 Tropical Medicine and Infectious Disease
🔗 DOI: 10.3390/tropicalmed9110255
👥 Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.

Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis & Soil-Transmitted Helminths in Ekiti State, Nigeria
🗓 2024-09-16 | Preprint
🔗 DOI: 10.20944/preprints202409.1200.v1
👥 Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.

Prof. Abdolkarim Sheikhi | Vaccine | Best Innovation Award

Queens University, Canada.

Abdolkarim Sheikhi is an Iranian immunologist and professor at Dezful University of Medical Sciences. With a distinguished career spanning over three decades, he has made significant contributions to the field of immunology, particularly in NK cell activity, immune responses, and molecular immunology. He has held key academic positions, supervised numerous research projects, and has been actively involved in establishing laboratories and clinical centers. His expertise extends to advanced immunological techniques, teaching, and scientific society memberships.

🎓 Education

Abdolkarim Sheikhi earned his B.Sc. in Biological Sciences from Shahid Chamran University, Iran (1985–1989), followed by an M.Sc. in Medical Immunology from Tarbiat Modarres University, Iran (1989–1992), where he researched Natural Killer (NK) activity assays in cancerous patients and normal individuals. He then completed his Ph.D. in Medical Immunology at Shiraz University of Medical Sciences, Iran (1996–2002), focusing on the influence of soluble HLA molecules on NK cells, particularly their quantity and role in malignant peritoneal and pleural effusions, shedding light on immune interactions in cancer progression.

💼 Experience

Professor Abdolkarim Sheikhi has had a distinguished academic career in Immunology, currently serving as a Professor at the Department of Immunology, Dezful University of Medical Sciences (2016–Present). Before this, he was an Associate Professor at the same institution (2010–2016) and at Zanjan University of Medical Sciences (2009–2010). His journey in academia began as an Assistant Professor (2002–2009) and an Academic Staff Member (1992–2002) at Zanjan University of Medical Sciences. In addition to his teaching and research, he has held Visiting Scientist positions at Queen’s University (Canada), Universitätsklinikum Kiel (Germany), and VUmc University (Netherlands), contributing to global immunology research.

🔬 Research Interests

Immunology: Natural Killer (NK) cells, immune regulation, immune responses in infections and cancers

Molecular Immunology: sHLA molecules, T cell activation, antigen presentation

Autoimmune Diseases & Allergies

Cancer Immunotherapy & Monoclonal Antibodies

📚 Selected Publications

Sheikhi, A., Baghaie, L., Rahbarizadeh, F., Safarzadeh Kozani, P., Moradian, C., Davidi, M., Baharifar, N., Kaboli, G., Sheikhi, M., Li, Y., et al. (2025).
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.
Vaccines.

Yazdanpanah‐Samani, M., Ramezani, A., Sheikhi, A., Mostafavi‐Pour, Z., Erfani, N. (2024).
Anti‐PD‐L1 Chimeric Antigen Receptor Natural Killer Cell: Characterization and Functional Analysis.
APMIS.

Akbarian, S., Sheikhi, M., Khedri, P., Baharifar, N., Khalaf Shamsabadi, F., Davidi, M. R., Khazaei, H. A., Assarian, H., Sheikhi, A. (2023).
The Correlation Between Humoral Immune Responses and Severity of Clinical Symptoms in COVID-19 Patients.
Epidemiology and Infection.

Momtazan, S., Ramezani, S., Momeni, A., Sheikhi, A. (2023).
The Potential Benefits of Ginger in Cancer Therapy.
Trends in Medical Sciences.